Biosysen (HKG:1355) completed the issuance of HK$50 million in convertible bonds to Osibao Cosmetics International on Aug. 5, settling amounts owed to the substantial shareholder.
The bonds were issued after all conditions under the subscription and settlement agreement were fulfilled, the company said in a Wednesday filing.
Shares of the company fell over 11% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments